Morocco’s Legal Cannabis Production Reaches 19,576 Quintals

Morocco has emerged as a pivotal player in Africa's regulated cannabis economy, with legal production reaching 19,576 quintals in 2025. This milestone represents a critical inflection point for the North African nation, which legalized medical and industrial cannabis cultivation in 2021 but has faced a slow transition from informal to formal supply chains. The production figure signals both the scale of Morocco's agricultural pivot and the persistent structural challenges that constrain growth in this nascent sector.

### Why Morocco's Cannabis Legalization Matters for Regional Markets

Morocco's regulatory framework—established under a 2021 presidential decree—permits licensed cultivation for medicinal, cosmetic, and industrial (fiber and seed) purposes, but explicitly excludes recreational use. This middle-ground approach has attracted international operators seeking compliant sourcing while maintaining political stability. The Kingdom positioned itself to capture European and Middle Eastern demand for CBD products, pharmaceutical ingredients, and textiles. However, the 19,576 quintal figure (approximately 1,958 metric tonnes) reflects only a fraction of Morocco's agricultural capacity, suggesting implementation gaps rather than demand constraints.

The regulatory environment remains opaque for foreign investors. Morocco's cannabis agency (ANRAC—established 2021) issues cultivation licenses, but transparency around approval timelines, land allocation, and export permits remains limited. International operators must navigate a dual-licensing system: cultivation permits from ANRAC plus separate export authorization from the Ministry of Health. These bureaucratic layers have slowed foreign direct investment compared to other African cannabis markets.

### What Does 19,576 Quintals Actually Mean for Supply Chains?

At current production levels, Morocco is capturing only a marginal share of global medicinal cannabis demand (estimated at $50+ billion by 2030). For context, Canada alone produces 350,000+ tonnes annually; Morocco's output is 0.5% of that scale. However, Morocco's competitive advantages—Mediterranean climate, established agricultural expertise, proximity to European markets, and lower labor costs—position it for exponential scaling. The question is timing: will ANRAC licensing accelerate or remain a bottleneck?

Industry analysts project Morocco could reach 50,000+ quintals by 2027 if regulatory reforms simplify licensing and land access. This would require tripling current capacity in 24 months—ambitious but feasible given the Kingdom's agricultural infrastructure. European pharmaceutical and CBD manufacturers are watching closely; several major pharmaceutical firms have already scouted partnerships in Morocco.

### Market Implications for Africa-Focused Investors

Morocco's cannabis economy has indirect ripple effects. Success here validates regulated cannabis as a credible African agribusiness model, potentially encouraging other nations (Lesotho, South Africa, Zimbabwe) to formalize their sectors further. It also signals Morocco's broader pivot toward high-margin agribusiness and biotech, attracting venture capital to the region beyond cannabis.

The domestic market remains untapped—medical cannabis is unavailable to Moroccan patients, a regulatory contradiction that limits local revenue. If the government expands patient access, domestic demand could accelerate. Export revenues, however, are the real prize: a mature Moroccan cannabis sector could generate $200–400 million annually in export value by 2030, rivaling smaller African commodity markets.

---

##